Repeat hepatitis B vaccination may lead to seroprotection in HIV-infected patients who do not respond to an initial series

Journal of Acquired Immune Deficiency Syndromes

Volumn 50, Issue 1, 2009, Pages 110-113

  Bloom, Allyson ^a   Jackson, Katherine ^a   Kiviat, Aurora ^a   Zheng, Hui ^a   Sax, Paul ^b   Gandhi, Rajesh ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS B ANTIBODY;

ADULT; ANTIBODY TITER; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; LETTER; MALE; PRIORITY JOURNAL; REPEAT PROCEDURE; TREATMENT RESPONSE; VACCINATION; VIRUS TRANSMISSION; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED;

EID: 64249136831     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318183acc0     Document Type: Letter

References (14)

1. Gandhi RT, Wurcel A, Lee H, et al. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Infect Dis. 2005;191:1435-1441.
2. Overton ET, Sungkanuparph S, Powderly WG, et al. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis. 2005;41: 1045-1048.
3. Laurence JC. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med. 2005;118: 75S-83S.
4. Colier AC, Corey L, Murphy VL, et al. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med. 1988;109: 101-105.
5. Loke RHT, Murray-Lyon IM, Coleman JC, et al. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis. J Med Virol. 1990;31:109-111.
6. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40:1-25.
7. Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986;315:209-214.
8. Rey D, Krantz V, Partisani M, et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine. 2000;18:1161-1165.
9. Tedaldi E, Baker R, Moorman A, et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis. 2004;38:1478-1484.
10. Elrefaei M, McElroy M, Preas C, et al. Central memory CD4 T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol. 2004; 173: 2184-2189.
11. Lange C, Lederman M, Medvik K, et al. Nadir CD4 T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS. 2003;17:2015-2023.
12. Overton E, Nurutdinova D, Sungkanuparph S, et al. Predictors of immunity after hepatitis A vaccination in HIV-infected persons. J Viral Hepat. 2007;14:189-193.
13. Falcó V, Jordano Q, Cruz M, et al. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study. Vaccine. 2006;24: 2567-2574.
14. de Vries-Sluijs T, Hansen B, van Doornum G, et al. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients. J Infect Dis. 2008;197:292-294.